Robert Herbst, DPM
Podiatrist · Florence, KYNPI 1487847331
Payments from drug & device makers
What this record shows
This record is dominated by other: $23,500 of the $24,160 with a category attached, or 97.3%. Convatec Inc. accounts for 97.4% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $23,535, more than ten times the $575 reported in 2019. Among podiatrist clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $635.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$24K
- Amgen$351
- Melinta Therapeutics, LLC$177
- Celularity Inc.$35
- Paratek Pharmaceuticals, Inc.$28
- Globus Medical$19
- plus $19 from 2 others
What the payments were for
- Food & beverage$6603%
- Other$23,50097%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 7 | $23,531 |
| Amgen | 23 | $351 |
| Melinta Therapeutics, LLC | 2 | $177 |
| Celularity Inc. | 1 | $35 |
| Paratek Pharmaceuticals, Inc. | 2 | $28 |
| Globus Medical | 1 | $19 |
| Merck | 1 | $12 |
| Reprise Biomedical, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$23,500
- KRYSTEXXA$116
How this compares
$24,160 in reported general payments places this provider in the 90th percentile of 54 podiatrist providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 14 | $254 |
| Ciclopirox | 12 | $219 |
| Meloxicam | 28 | $130 |
| Furosemide | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Florence
- Thomas ChildressLouisville$283K
- Joshua CogerLouisville$132K
- David SmithHopkinsville$66K
- Matthew FeltnerCampbellsville$38K
- Zachery WeyandtLouisville$37K
- Michael AllenLexington$24K
- Thomas PoynterDanville$20K
- Andrew BouwkampLouisville$19K
- Braxton RiderLouisville$10K
- Ryan SherryLouisville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.